SUMMARY
The effects of different doses of pregnant mare serum gonadotrophin (PMS) were examined in 29-day-old immature rats; a dose great enough to produce follicles capable of ovulating in response to the additional injection of human chorionic gonadotrophin (HCG) 56 hr. later in the majority of animals also caused significant oestrogen secretion as judged by uterine weight. Maximal uterine growth resulted from doses of PMS that led to a significant incidence of 'spontaneous' ovulation. In contrast, administration of ovine follicle-stimulating hormone (FSH) resulted in the ripening of large numbers of follicles with much less evidence of oestrogen secretion; 'spontaneous' ovulation did not occur in FSH-treated animals but ovulation could be induced by additional treatment with oestrogen and progesterone in combination but not by either steroid alone. Previous exposure to oestrogen appears to be necessary for the facilitatory action of progesterone on luteinizing hormone release to be demonstrable and the FSH-primed immature rat is a convenient preparation to study this interaction.
The relationship between changes of serum immuno-reactive cholecystokinin-pancreozymin (CCK-PZ) and serum immuno-reactive insulin has been studied after various stimuli. The oral administration of 5 percent glucose or magnesium sulphate and the intra-duodenal administration of olive oil were all followed by a rise of serum CCK-PZ. The serum insulin rose after 5 percent glucose and also showed a small but insignificant rise with olive oil. There was, however, no change of serum insulin after the ingestion of magnesium sulphate suggesting that CCK-PZ in isolation does not stimulate insulin release.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.